| 2025 | 2024 | 2023 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | 131,7 k € | |||||||||||||
| Gross margin | 77,0 k € | +13.7% | 67,7 k € | -3.5% | 70,1 k € | +47.5% | 47,6 k € | +16.5% | 40,8 k € | +17.9% | 34,6 k € | -25.8% | 46,7 k € | +41.0% | 33,1 k € | -25.1% | 44,2 k € | +65.2% | 26,8 k € | -16.7% | 32,1 k € | +33.6% | 24,0 k € | -20.7% | 30,3 k € | |
| EBITDA | 74,6 k € | +14.8% | 64,9 k € | -4.4% | 68,0 k € | +50.4% | 45,2 k € | +15.8% | 39,0 k € | +18.4% | 33,0 k € | -26.7% | 45,0 k € | +44.3% | 31,2 k € | -25.7% | 42,0 k € | +70.2% | 24,7 k € | -21.1% | 31,2 k € | +37.6% | 22,7 k € | -13.2% | 26,2 k € | |
| Operating profit | 61,7 k € | +20.2% | 51,3 k € | -5.0% | 54,0 k € | +72.9% | 31,2 k € | +72.5% | 18,1 k € | +45.7% | 12,4 k € | -49.2% | 24,5 k € | +124.0% | 10,9 k € | -50.2% | 21,9 k € | +91.0% | 11,5 k € | -33.9% | 17,4 k € | +59.5% | 10,9 k € | -19.3% | 13,5 k € | |
| Profit/loss | 44,3 k € | +21.0% | 36,6 k € | -7.2% | 39,5 k € | +89.6% | 20,8 k € | +128.1% | 9,1 k € | +16.8% | 7,8 k € | -52.8% | 16,6 k € | +173.0% | 6,1 k € | -61.5% | 15,8 k € | +107.2% | 7,6 k € | -35.9% | 11,9 k € | +65.8% | 7,2 k € | -18.4% | 8,8 k € | |
| Equity | 224,0 k € | +19.5% | 187,5 k € | +21.5% | 154,3 k € | +12.6% | 137,1 k € | +34.9% | 101,6 k € | +9.9% | 92,5 k € | +7.2% | 86,3 k € | +23.8% | 69,7 k € | +9.5% | 63,6 k € | +33.0% | 47,8 k € | +18.9% | 40,2 k € | +41.9% | 28,3 k € | +33.8% | 21,2 k € | |
| Total assets | 248,1 k € | +18.2% | 209,8 k € | +6.2% | 197,5 k € | +13.2% | 174,5 k € | +1.3% | 172,3 k € | -6.7% | 184,6 k € | -13.9% | 214,5 k € | -1.5% | 217,9 k € | -19.8% | 271,6 k € | +22.4% | 221,9 k € | -5.9% | 235,8 k € | +15.6% | 204,0 k € | +80.0% | 113,3 k € | |
| Cash | 154,5 k € | +54.3% | 100,1 k € | +29.5% | 77,3 k € | +81.6% | 42,6 k € | +83.9% | 23,1 k € | +120.7% | 10,5 k € | -41.8% | 18,0 k € | +75.1% | 10,3 k € | -78.2% | 47,2 k € | +1091.9% | 4,0 k € | -66.7% | 11,9 k € | +53.3% | 7,7 k € | +65.5% | 4,7 k € | |
| Debts | 21,3 k € | +12.1% | 19,0 k € | -52.1% | 39,7 k € | +22.5% | 32,4 k € | -51.7% | 67,1 k € | -25.2% | 89,7 k € | -28.7% | 125,7 k € | -13.3% | 145,0 k € | -29.2% | 204,8 k € | +19.4% | 171,5 k € | -11.1% | 193,1 k € | +11.5% | 173,2 k € | +93.2% | 89,6 k € | |
Private limited company · Gent · incorporated on 22/09/2010
Private limited company profitable and well capitalised. Cash position rising (+54.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Lolophar is a Private limited company incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Gent.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette